2023 Partners

Hycult Biotech

Hycult Biotech

Expertise Partner

Hycult Biotech is a ISO-13485 certified manufacturer of research reagents in the field of innate immunity since 1994. We have an extensive knowledge in the development and production of assays, antibodies and proteins. Our products are co-developed with leading scientists over the world. These close collaborations lead to reliable and reproducible research tools that enable better disease understanding and monitoring.

Hycult Biotech is private company operating from its headquarters in Uden, The Netherlands. At this location products are developed, manufactured and stored. Our products are made available through the Dutch headquarters, our sales office in Wayne (PA) USA and distributors present in more than 50 countries.

www.hycultbiotech.com

Kypha

Kypha

Hosting Partner

Kypha is delivering immune insights driven by the need for reliable and actionable immune activation results in any clinical setting. Kypha’s complement activation diagnostics program focuses on reducing sample management requirements and removing preanalytical variability. As a result, Kypha’s platforms are designed for low complexity protocols with disease specific multiplex testing panels and are currently deployed to clinical sites for validation and partner collaborations. Kypha was founded in 2010 with headquarters in St. Louis, MO, USA and Dublin, Ireland.

www.kypha.net

Machaon Logo

Machaon Diagnostics

Innovation Partner

By providing rapid turnaround times and expedited study services, Machaon Diagnostics has grown a reputation for supporting the laboratory needs of the pharmaceutical and CRO industries. Examples of what sets us apart include: clinical-grade NGS gene sequencing results in 48 hours, sC5b-9 levels in <24 hours (7 days a week), Rare Disease Subject and Site Finder. Machaon Diagnostics is composed of two CAP/CLIA accredited reference laboratories, a central laboratory and a Rare Disease CRO.

www.machaondiagnostics.com

svar logo

Svar Life Science

Innovation Partner

Svar means 'answers' in Swedish. We are a life science company with proud Scandinavian roots and values, and a global perspective. We focus on helping deliver the answers needed in drug discovery and clinical diagnostics, and the impact this has on human lives.
Svar is in a unique position to offer assistance in any complement therapeutic development project. We have robust platforms suited for all phases of drug development, as well as experience and knowledge from our diagnostic and bioanalytical services.

www.svarlifescience.com

Sanquin

Sanquin

Innovation Partner

At Sanquin Pharma & Biotech Services we pride ourselves on our expertise in blood and the ABCs (Antibodies/Biomarkers/Cells) contained and interacting within. We are your partner to map out complex processes, study disease activity, conduct safety, efficacy and pharmacokinetic studies, and develop your custom disease-specific TDM assays. Sanquin PBS is ideally positioned to conduct your pre-clinical complement-based drug development research, by comprehensively mapping out your drug candidate’s properties and its effects on the complement cascade and disease activity.

www.sanquin.org

National Jewish Health

National Jewish Health

Exhibition Partner

National Jewish Health Advanced Diagnostic Laboratories offer pre-clinical, clinical safety/tox and biomarker efficacy testing services under CAP/CLIA/ISO15189 guidelines. Our Complement Laboratory offers the most comprehensive test menu in the industry.  Customized study design and data analysis based on the experience from 100+ studies filed with regulatory agencies, assessing patient status, target engagement, complement activation and immune complex formation for small molecule, biologics, vaccines and oligonucleotide based therapeutics.  For more information, visit njlabs.org

njlabs.org

MicrosoftTeams-image (4)

QuidelOrtho

Exhibition Partner

QuidelOrtho Specialty Products Group (SPG) Complement System products are a well-established name in immune system monitoring, providing a variety of first-in-class diagnostic and research solutions. The SPG product portfolio includes ELISA assays, multiplex, antibodies, proteins, and sera based products such as depleted sera, normal human serum, and cobra venom factor. Our products cover many of the intact and activation proteins of the complement system for a comprehensive product portfolio.

www.quidel.com

Kira Pharmaceuticals logo

Kira Pharmaceuticals

Event Partner

Kira Pharmaceuticals is a clinical-stage biopharmaceutical company, engaged in the discovery and development of novel therapies to treat diseases and disorders caused by the dysregulation of the complement system. Founded by world renowned experts in complement biology, Kira is pioneering the field by developing a pipeline of compelling therapies leveraging its LOGIC drug discovery platform. With nine (9) novel assets in the pipeline spanning targets across the complement cascade, including the lead program, KP104, which is a bifunctional C5/Alternative Pathway asset entering Phase 2, Kira is committed to establishing a global footprint to advance life-changing therapies that will transform the lives of patients with complement-driven diseases. Kira Pharmaceuticals is headquartered in Boston with additional offices and research activities in China.

www.kirapharma.com

amgen

Amgen

Industry Partner

Amgen harnesses the best of biology and technology to make people’s lives easier,
fuller, and longer. We draw upon our deep knowledge of science to push beyond what’s known today. With roots in the biotech revolution, we are one of the world’s leading independent biotech companies – fighting the toughest diseases and helping millions of people globally.

www.amgen.com